More than a million Australians are projected to develop dementia in the next four decades, with the number of early onset ...
Nonprofit senior living operator FellowshipLife recently launched a new, voluntary genetic testing program for residents and their families aimed at ...
Zacks Investment Research on MSN
Quanterix submits FDA 510(k) for multi-analyte Alzheimer's blood test
Quanterix QTRX recently announced the submission of a 510(k) premarket notification to the FDA for its multi-analyte ...
Our team at the UK Dementia Research Institute’s Biomarker Factory at UCL are part of the global effort working to develop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results